SPTK vs IKT
Comparison between SportsTek Acquisition Corp - Class A (SPTK, Company) and Inhibikase Therapeutics Inc (IKT, Company).
SPTK vs IKT - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
SPTK
$219M
Winner
IKT
$219M
Max Drawdown
Winner
SPTK
3.90%
IKT
98.64%
Sharpe Ratio
Winner
SPTK
0.12
IKT
0.08
5Y Beta
SPTK
N/A
IKT
1.38
Industry
SPTK
N/A
IKT
Biotechnology
P/E Ratio
SPTK
86.49
Winner
IKT
-3.23
Debt to Equity
SPTK
0.00%
IKT
0.00%
Free Cash Flow Yield
Winner
SPTK
-0.43%
IKT
-16.31%
P/S Ratio
SPTK
N/A
IKT
10.39
P/B Ratio
Winner
SPTK
-29.56
IKT
1.31
SPTK vs IKT - Historical Returns
Returns include dividend reinvestment.
1M
Winner
SPTK
+1.40%
IKT
-13.02%
3M
Winner
SPTK
+3.26%
IKT
-16.08%
6M
SPTK
+3.78%
Winner
IKT
+8.44%
1Y
Winner
SPTK
+4.75%
IKT
-12.57%
5Y(CAGR)
SPTK
N/A
IKT
-45.80%
Max(CAGR)
Winner
SPTK
+0.87%
IKT
-47.96%
SPTK vs IKT - Annual Returns (2020 - 2026)
Returns include dividend reinvestment.
| Year | SPTK | IKT |
|---|---|---|
| 2026 | N/A | -14.36% |
| 2025 | N/A | -37.69% |
| 2024 | N/A | +144.03% |
| 2023 | N/A | -60.96% |
| 2022 | +4.21% | -69.70% |
| 2021 | -2.30% | -78.88% |
| 2020 | N/A | -30.30% |
SPTK vs IKT Drawdown Comparison
The maximum drawdown for SPTK was -3.90%, occurring on Aug 20, 2021. Recovery took 403 trading sessions.
The maximum drawdown for IKT was -98.64%, occurring on Oct 9, 2023. This drawdown has not yet recovered.
The current SPTK drawdown is -0.88%. The current IKT drawdown is -97.19%.
| Rank | SPTK | IKT |
|---|---|---|
| #1 | -3.90% Apr 9, 2021 - Nov 11, 2022 | -98.64% Dec 23, 2020 - Oct 9, 2023 |
| #2 | -2.15% Dec 15, 2022 - Dec 19, 2022 | N/A |
| #3 | -0.40% Nov 11, 2022 - Nov 29, 2022 | N/A |
| #4 | -0.30% Dec 7, 2022 - Dec 15, 2022 | N/A |
| #5 | -0.20% Nov 29, 2022 - Dec 7, 2022 | N/A |
Correlation
Correlation between SPTK and IKT is -0.56 which considered as a moderate negative correlation - the stocks show some tendency to move in opposite directions.
-0.56
-101
Select Stocks to Compare
Popular: SPTK vs SPYIKT vs SPY
More Comparisons
Compare with similar stocks